BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260807
DTEND;VALUE=DATE:20260809
DTSTAMP:20260614T151721Z
CREATED:20260614T151721Z
LAST-MODIFIED:20260614T151721Z
UID:10000761-1786060800-1786233599@oncodaily.com
SUMMARY:2026 Summit for Novel Therapeutics in Oncology and Precision Medicine in Cancer (STOP Cancer)
DESCRIPTION:The 2026 Summit for Novel Therapeutics in Oncology and Precision Medicine in Cancer (STOP Cancer) will bring together many of the world’s leading oncology researchers\, physician-scientists\, and clinical innovators on August 7-8\, 2026\, at the New York Marriott Marquis in Times Square. \nThe multidisciplinary conference is designed to bridge groundbreaking translational research with real-world patient care\, highlighting the latest advances in precision medicine\, targeted therapies\, antibody-drug conjugates (ADCs)\, biomarker-driven treatment strategies\, immunotherapy\, radiopharmaceuticals\, and early-phase clinical trials. The program will feature nationally recognized experts from leading institutions including Memorial Sloan Kettering Cancer Center\, Stanford Cancer Institute\, Mayo Clinic\, Dana-Farber Cancer Institute\, Vanderbilt University Medical Center\, MD Anderson Cancer Center\, and NEXT Oncology. \nAmong the distinguished faculty is Dr. Sarat Chandarlapaty of Memorial Sloan Kettering Cancer Center\, who will deliver the prestigious Daniel D. Von Hoff Keynote Lecture. Dr. Chandarlapaty is internationally recognized for his contributions to breast cancer research and precision oncology. \nThe summit also features an exceptional lineup of speakers who are helping define the future of cancer therapeutics\, including: \n• Dr. Vivek Subbiah\, Stanford Cancer Institute\, a globally recognized leader in drug development and precision oncology\, presenting on the evolution and future of tumor-agnostic therapies. \n• Dr. Eileen M. O’Reilly\, Memorial Sloan Kettering Cancer Center\, one of the nation’s foremost experts in gastrointestinal malignancies\, discussing recent precision medicine advances in GI cancers. \n• Dr. Alexander I. Spira\, Chief Scientific Officer of NEXT Oncology\, presenting emerging developments in RAS-targeted therapies and next-generation oncology drug development. \n• Dr. Anthony W. Tolcher\, Founder and CEO of NEXT Oncology and a pioneer in early-phase clinical trials\, discussing innovative approaches including RAS PROTACs and molecular glues. \n• Dr. Cathy Eng\, Vanderbilt University Medical Center and Co-Chair of the National Cancer Institute Gastrointestinal Steering Committee\, presenting on ctDNA applications and biomarker-driven management strategies in colorectal cancer. \n• Dr. Vamsi Velcheti\, Mayo Clinic\, an internationally recognized thoracic oncologist and cancer researcher\, discussing the development of antibody-drug conjugates in lung cancer. \n• Dr. Guru P. Sonpavde\, AdventHealth Cancer Institute\, a leading investigator in genitourinary oncology and phase I clinical research\, presenting on ADC innovation in GU malignancies. \n• Dr. Eytan Stein\, Memorial Sloan Kettering Cancer Center\, one of the nation’s leading leukemia drug development experts\, discussing precision medicine advances in myeloproliferative neoplasms. \n• Dr. Ghassan K. Abou-Alfa\, Memorial Sloan Kettering Cancer Center\, a globally respected authority in hepatobiliary cancers\, presenting emerging innovations in HER2-targeted therapy. \n• Dr. Ulka Vaishampayan\, University of Michigan Rogel Cancer Center\, discussing advances in alpha-emitter radiopharmaceutical therapies for prostate cancer. \nAdditional presentations will explore emerging TP53-targeted therapies\, PRMT5 inhibitors\, novel biomarker methodologies\, digital biomarkers\, clinical trial innovation\, patient-reported outcomes\, decentralized clinical trials\, and next-generation immunotherapy approaches. \n“The pace of innovation in oncology has never been greater\,” said Dr. Hani Babiker\, Course Director and Associate Professor of Medicine at Mayo Clinic. “STOP Cancer was created to provide a forum where clinicians\, researchers\, and healthcare professionals can engage directly with leaders developing the therapies and technologies that will shape the future of cancer care.” \nThe conference is intended for medical oncologists\, hematologists\, radiation oncologists\, surgical oncologists\, advanced practice providers\, pharmacists\, nurses\, fellows\, researchers\, and other healthcare professionals involved in cancer care. \nRegister now.
URL:https://oncodaily.com/event/precision-medicine-520908
LOCATION:New York Marriott Marquis\, 1535 Broadway\, New York\, NY\, 10036\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/Annotation-2026-06-14-191317.webp
ORGANIZER;CN="Horizon CME":MAILTO:info@horizoncme.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260807
DTEND;VALUE=DATE:20260809
DTSTAMP:20260803T193143Z
CREATED:20260803T193129Z
LAST-MODIFIED:20260803T193143Z
UID:10000857-1786060800-1786233599@oncodaily.com
SUMMARY:APP Cancer Research Summit 2026
DESCRIPTION:The APP Cancer Research Summit 2026\, presented by the Advanced Practice Providers Oncology Summit (APPOS)\, will take place on 7–8 August 2026 at the New York Marriott Marquis in New York City. \nDesigned specifically for advanced practice providers working across the oncology research continuum\, the two-day conference will cover clinical-trial fundamentals\, developing and leading independent research\, expanding the APP’s role within research teams\, and emerging trends in oncology research. The Summit will be held alongside the Summit for Novel Therapeutics in Oncology & Precision Medicine in Cancer (STOP Cancer)\, providing additional opportunities for education\, collaboration\, and networking.
URL:https://oncodaily.com/event/app-cancer-research-558653
LOCATION:New York Marriott Marquis\, 1535 Broadway\, New York\, NY\, 10036\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ACRS_logo_16x9_exact.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260813
DTEND;VALUE=DATE:20260817
DTSTAMP:20260730T165005Z
CREATED:20260730T165005Z
LAST-MODIFIED:20260730T165005Z
UID:10000845-1786579200-1786924799@oncodaily.com
SUMMARY:29th Annual Oncology Symposium for the Healthcare
DESCRIPTION:The 29th Annual Oncology Symposium for the Healthcare Provider\, organized by the Association of PAs in Oncology (APAO)\, will take place on 13–16 August 2026 at the New York Marriott Marquis in New York City. \nDesigned for oncology healthcare professionals\, the symposium will feature expert-led education\, practical discussions\, and updates across hematology and oncology\, radiation oncology\, and palliative and supportive care. Participants will be able to explore current best practices\, discover innovative approaches that can be incorporated into clinical practice\, connect with colleagues and industry experts\, and learn about emerging technologies and solutions from exhibitors and sponsors. APAO is the national professional organization representing physician associates working across oncology disciplines. \nRegister Today.
URL:https://oncodaily.com/event/oncology-symposium-for-the-healthcare-555266
LOCATION:New York Marriott Marquis\, 1535 Broadway\, New York\, NY\, 10036\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/association-of-physician-assistants-in-oncology-save-the-date-annual-oncology-symposium-new-york-city-august-2026-rectangle.webp
ORGANIZER;CN="Association of PAs in Oncology (APAO)":MAILTO:admin@apao.cc
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260918T080000
DTEND;TZID=America/Halifax:20260919T170000
DTSTAMP:20260607T153427Z
CREATED:20260607T153427Z
LAST-MODIFIED:20260607T153427Z
UID:10000743-1789718400-1789837200@oncodaily.com
SUMMARY:NCCN 2026 Annual Congress: Hematologic Malignancies
DESCRIPTION:The NCCN 2026 Annual Congress: Hematologic Malignancies is scheduled for Friday\, September 18 – Saturday\, September 19\, 2026\, in New York\, NY\, and virtually. \nThis 2-day\, CE-certified congress highlights treatment advances\, unique patient cases\, and supportive care options for a variety of hematologic malignancies while demonstrating how to apply the NCCN Guidelines to optimize patient care. The program features over 21 live and on-demand sessions\, offering more than 13 CME/CE hours and an interactive environment for oncology professionals\, patient advocates\, and industry representatives to network and engage in live Q&A sessions with leading experts. \nRegister Now.
URL:https://oncodaily.com/event/hematologic-malignancies-516777
LOCATION:New York Marriott Marquis\, 1535 Broadway\, New York\, NY\, 10036\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/BeFunky-collage-2026-06-07T193259.524.webp
END:VEVENT
END:VCALENDAR